Valeo Pharma Inc.
- Home
- Companies
- Valeo Pharma Inc.
- Products
- Onstryv - Safinamide Tablets
Onstryv - Safinamide Tablets
The first Parkinson’s Disease (PD) treatment in Canada since 2006, providing relief of symptoms during the off-phase in dopamine treated patients.
Most popular related searches
ONSTRYV®
Safinamide tablets (as safinamide mesylate)
Available Strengths
50 mg tablets DIN 02484641
100 mg tablets DIN 02484668